ELISA News and Research

RSS

The first dose response for SARS-CoV-2 solution exposed to UV222

Researchers used culture and molecular assays to provide the first dose-response for SARS-CoV-2 solution exposed to UV222.

30 Aug 2022

Study identifies two potential serological biomarkers of monkeypox infection

In a new study, researchers pursued two monkeypox virus (MPXV) immune targets, A35R and H3L, that could be deployed in a serological assay to identify recent MPXV cases.

29 Aug 2022

Study shows SARS-CoV-2 infection provides strong protection from reinfection

Researchers assess the durability and effectiveness of immune responses against SARS-CoV-2 in terms of spike-binding antibody titers.

29 Aug 2022

Susceptibility of deer mice and California mice to COVID-19

In a new study, researchers assessed the susceptibility of deer mice and California mice to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

25 Aug 2022

Study investigates factors that influence immune responses over 15 months after SARS-CoV-2 infection

In a new study, the long-term humoral immunity to SARS-CoV-2 was investigated.

25 Aug 2022

What is the association between T lymphocyte-mediated immune responses and COVID-19 severity?

Researchers examined the relationship between cell-mediated or T lymphocyte-mediated immunity and SARS-CoV-2 infection severity.

25 Aug 2022

Vertical transfer of humoral immune protection after maternal SARS-CoV-2 vaccination

In a new study, researchers assessed the presence, durability, and neutralization potency of immunoglobulin G and IgA antibodies against SARS-CoV-2 in breastfeeding infant stools, maternal plasma, and breast milk following maternal COVID-19 vaccination.

24 Aug 2022

SARS-CoV-2 variant neutralization and novel mAbs reveal protection against Omicron in new research

Researchers assessed the SARS-CoV-2 variants of concern (VOCs) transmission dynamics and neutralization by vaccine-induced antibodies and monoclonal antibodies (mAbs).

19 Aug 2022

Waning of humoral immune responses to SARS-CoV-2 after 14 months of infection

Researchers assessed humoral immune responses to and neutralization of the SARS-CoV-2 Delta (B.1.617.2) variant of concern after two months (T1) and 14 months (T2) of asymptomatic or mild wild-type (WT) SARS-CoV-2 infections.

18 Aug 2022

CD98 identified as a key mediator of pro-fibrotic and acute inflammatory responses in the lung

Researchers investigated the role of the CD98 glycoprotein in inducing an inflammatory response to SARS-CoV-2 in patients of progressive fibrosis interstitial lung diseases, including the archetypal PFILD, idiopathic pulmonary fibrosis.

18 Aug 2022

Impact of SARS-CoV-2 Omicron subvariant breakthrough infections on memory responses

Researchers examined antibodies (Abs) generated by memory B cells (MBCs) after three and four SARS-CoV-2 exposures by infections with SARS-CoV-2 Delta and Omicron BA.1 variants, respectively.

16 Aug 2022

Comparison of seroconversion rates and antibody responses in children across the three SARS-CoV-2 waves in Melbourne, Australia

Researchers evaluated antibody responses to SARS-CoV-2 variants in children.

16 Aug 2022

Is the level of circulating SARS-CoV-2 RNA or spike protein associated with acute disease severity?

Researchers investigated the levels of circulating SARS-CoV-2 spike protein and viral RNA among patients hospitalized with acute COVID-19 and in patients with and without post-acute sequelae of COVID-19.

15 Aug 2022

Do pre-existing antibodies alter the development of memory B cells in response to SARS-CoV-2 mRNA vaccination in humans?

Researchers explored how passive administration of monoclonal antibodies impact the development of immunological memory in response to COVID-19 vaccination.

15 Aug 2022

In monkeys, spike-based vaccines produce some immunity based on CD8 T-cells

Scientists evaluate the role of CD8+ T-cells in vaccine protection against SARS-CoV-2 infection in rhesus macaques.

14 Aug 2022

Bispecific antibody exhibits high breadth and potency against SARS-CoV-2 Omicron sub-lineages

In a new study, researchers developed bispecific-antibodies (bsAbs) against SARS-CoV-2 Omicron sub-lineages.

12 Aug 2022

Study warns of a potential Sindbis virus epidemic in 2022

Researchers seek to raise awareness of a potentially impending Sindbis virus epidemic.

11 Aug 2022

Crying out for new disease diagnoses

In this interview, we speak to Dr. Fei Liu and Dr. Luke P. Lee about their new iTears platform and how it could help to diagnose disease from tears.

11 Aug 2022

A novel 3D-printed lab-on-a-chip device concurrently detects SARS-CoV-2 nucleic acid and anti-SARS-CoV-2 antibodies in saliva

Researchers described the development and applications of a 3D-printed lab-on-a-chip device that quickly detected the presence of SARS-CoV-2 in patient's saliva.

10 Aug 2022

Poor mental health during COVID-19 pandemic associated with weight gain in people with obesity

Over the first year of the COVID-19 pandemic, almost 30% of patients with obesity gained more than 5% of their body weight, and 1 in 7 gained more than 10%.

9 Aug 2022

ELISA News and Research

The first dose response for SARS-CoV-2 solution exposed to UV222

Study identifies two potential serological biomarkers of monkeypox infection

Study shows SARS-CoV-2 infection provides strong protection from reinfection

Susceptibility of deer mice and California mice to COVID-19

Study investigates factors that influence immune responses over 15 months after SARS-CoV-2 infection

What is the association between T lymphocyte-mediated immune responses and COVID-19 severity?

Vertical transfer of humoral immune protection after maternal SARS-CoV-2 vaccination

SARS-CoV-2 variant neutralization and novel mAbs reveal protection against Omicron in new research

Waning of humoral immune responses to SARS-CoV-2 after 14 months of infection

CD98 identified as a key mediator of pro-fibrotic and acute inflammatory responses in the lung

Impact of SARS-CoV-2 Omicron subvariant breakthrough infections on memory responses

Comparison of seroconversion rates and antibody responses in children across the three SARS-CoV-2 waves in Melbourne, Australia

Is the level of circulating SARS-CoV-2 RNA or spike protein associated with acute disease severity?

Do pre-existing antibodies alter the development of memory B cells in response to SARS-CoV-2 mRNA vaccination in humans?

In monkeys, spike-based vaccines produce some immunity based on CD8 T-cells

Bispecific antibody exhibits high breadth and potency against SARS-CoV-2 Omicron sub-lineages

Study warns of a potential Sindbis virus epidemic in 2022

Crying out for new disease diagnoses

A novel 3D-printed lab-on-a-chip device concurrently detects SARS-CoV-2 nucleic acid and anti-SARS-CoV-2 antibodies in saliva

Poor mental health during COVID-19 pandemic associated with weight gain in people with obesity

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News